Building Blocks

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Tert-butyl 3-bromopropionate is a linker for the synthesis of pleuromutilin derivatives. It has been used as a model substrate for studying the effects of hypertrophy on cardiac muscle. Tert-butyl 3-bromopropionate has also been shown to inhibit the production of proinflammatory cytokines in response to bacterial infection, and can be used as an antibacterial agent. Tert-butyl 3-bromopropionate binds to RNA and inhibits protein synthesis, which leads to cell death by preventing the production of proteins vital for cell division. Tert-butyl 3-bromopropionate is also a potent inhibitor of chloride channels that are found in nerve cells and prevents the flow of chloride ions through these channels, leading to paralysis. This drug also inhibits hydrogen fluoride excretion in rats, which may be due to its ability to bind with chloride ions in the kidney tubules, preventing their

Bromoacetaldehyde diethyl acetal (BDAE) is an organic compound that has been shown to have receptor binding activity. BDAE binds to the ethylene diamine receptor and competes with ethylene diamine for binding sites. It also forms acid from sodium carbonate and hydrochloric acid, which may be due to its ability to act as a solid catalyst. BDAE has shown activity in hiv infection, with a potency comparable to that of dimethyl fumarate. The synthesis of BDAE can be accomplished by reacting monosodium malonate ester hydrochloride with adenine nucleotide and malonic acid. The reaction solution is heated until the desired product crystallizes out of solution.

Please enquire for more information about 5-Bromo-1-methyl-1H-1,2,3-triazole including the price, delivery time and more detailed product information at the technical inquiry form on this page

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

4-Amino-2-hydroxybenzamide is an aminoaryl amide that is produced by the thermal decomposition of 4-amino-2,6-dihydroxyphenylacetamide. It has been shown to be a potent inhibitor of the growth of bacteria and yeast, including Mycobacterium tuberculosis. The inhibitory effect was found to be due to inhibition of RNA synthesis as well as protein synthesis. This compound has also been shown to be effective against other types of microorganisms such as Pseudomonas aeruginosa and Staphylococcus aureus.

Versatile small molecule scaffold

Versatile small molecule scaffold

Trimethyl(trichloromethyl)silane is a chlorinating agent that reacts with hydrocarbons to form quinones. It is synthesized in the liquid phase and reacts with aldehydes, amines, and sodium formate to produce the trichloromethylated product. Trimethyl(trichloromethyl)silane is activated by electron deficiency and can be used to circumvent functional groups such as hydroxyl or carbonyl. This chemical also has properties that are not shared by other chlorinating agents, such as its ability to react with hydrogen fluoride without forming hydrochloric acid.

Versatile small molecule scaffold

Versatile small molecule scaffold

Piperazine-1-sulfonamide is a protein inhibitor that belongs to the group of regulatory agents. It is used to regulate the growth of various types of cells, including immune cells and smooth muscle cells. Piperazine-1-sulfonamide has been shown to inhibit chemokine receptor activity in inflammatory bowel disease, which may be due to its ability to inhibit CXCR4 and CCR5 receptors. This drug also inhibits dpp-iv, an enzyme involved in protein degradation. The pharmacokinetic properties of this agent are not well studied, but it does show toxicity studies in rats at higher doses. Piperazine-1-sulfonamide can cause congestive heart failure and liver damage at high doses, so it should not be used for prolonged periods of time.